150 likes | 299 Views
Global Facts- Type 2 Diabetes. Currently 150 Million people worldwide suffering from diabetes and that number may double by the year 2025. The prevalence of type 2 diabetes is dramatically increasing among adolescents and teenages.
E N D
Global Facts- Type 2 Diabetes • Currently 150 Million people worldwide suffering from diabetes and that number may double by the year 2025. • The prevalence of type 2 diabetes is dramatically increasing among adolescents and teenages. • The death risk is 1.5 or 2.5 times bigger in people with diabetes than healthy people. WHO Technical Report series, No: 916, 2003
Yet, worldwide there is a pandemic of type II diabetes and associated metabolic syndrome continue to take up an important space. • More than 10 % developing end-stage renal disease unless effective measures of early detection and intervention programs are initiated.
Global Facts -Hypertension • Hypertension causes cerebrovascular diseases (62 %) and iskemic heart disease (49 %). • Worldwide, high blood pressure is estimated to cause 7.1 million (13%) deaths. The World Health Report, 2002
HYPERTENSION • High Incidence of Hypertension • Cardiovascular and Renal Risk Increase: In USA: - 2002….. 261.000 mortality - 2005…..expenditure is 59 billion USD. A Serious Public Health Problem. .
The Studies on Hypertension Prevalance • WHO MONICA Project: Multinational MONİtoring of Trends and Determinants in CArdiovascular Disease • Closer Countries • Hypertension prevalence and Blood Pressure Levels in 6 European Countries, Canada and United States • NHANES National Health and Nutrition Examination Survey
The consequences are rather interesting: • In Indian Males in Rural Regions 3.4 % • In Polish Females 72 % • Incidence in developed countries 20-50 % The Seventh Report of the Joint National Committee onPrevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7)
The Prevalance Studies on Hypertension in Turkey (2004 ) In our country ; • There are 15 million hypertensives in adult population. • 40 percent of them are aware that having high blood pressure. • 31 percent of them have anti hypertensive therapy. Turkish Hypertension and Renal Diseases Association.
World Kidney Day Campaign aimed to reach basic targets in longer term. • Industry, the organizations which don’t belong to governments • National or Worldwide related organizations • Performers of Education and Policy, Public started to globally promote the campaign.
The public health mandate is clear for governments • Detection and prevention are the most cost effective methods to address chronic kidney disease and its impact on diabetes and cardiovascular disease. • www.world kidneyday.org
THE REAL PROBLEMS WE FACE • Worldwide, most individuals with chronic kidney disease or hypertension are not diagnosed until long after the illness has developed. • Moreover, when they are diagnosed, they too often are treated suboptimally or not at all. • In most parts of the world, once end-stage kidney failure occurs, patients do not have access to maintenance hemodialysis treatment or kidney transplantation • And simply die.
For these problems, it is time to speak up and to speak clearly. • Because the extent and severity of kidney disease has not been appreciated for a long time. • Not only past, but also currently. • Moreover, the availability of easy methods for early detection and the proven benefits of preventive therapy are not widely known. • A day when attention to kidney disease is brought to the world’s population is timely. • It could also serve as a day to express appreciation for the billions of dollars of support for a disease that currently requires high- technology treatment.
A day when we have to emphasize that early detection is more important in treatment.
Cardiovascular complications can be prevented and effectively treated with • Intensive blood pressure control, • Glucose control in diabetic patients, • Lipid Lowering medications and use of kidney protective medications For instance: Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.